Abstract
Marrow culture from mice has been reported to be overgrown by non-mesenchymal cells. In almost all protocols for isolation of murine mesenchymal stem cells (MSCs), high density culture systems have been employed. Since MSCs are colonogenic cells, the initiating cell seeding density may have significant impact on their cultures. This subject was explored in this study. For this purpose, the bone marrow cells from NMRI mice were plated at 2.5 × 106 cells/cm2 and upon confluency were reseeded as either low density (50 cells/cm2) or high density (8 × 104 cells/cm2) cultures. The cells were expanded through an additional subculture and the passage 2 cells as a product of two culture systems were statistically compared with respect to their surface antigen profiles and osteogenic culture mineralization. While low density culture grew with multiple colony formation, there were no distinct colonies in high density cultures. In contrast to high density cultures, passage 2 cells from low density system possessed typical homogenous fibroblastic morphology. Some cells from high density system but not the low density cultures expressed hematopoietic and endothelial cell markers including CD135, CD34, CD31, and Vcam surface antigens. Furthermore, osteogenic cultures from low density system displayed significantly more mineralization than those from high density system. Taken together, it seems that low density culture system resulted in more purified MSC culture than its counterpart as high density culture system.
Similar content being viewed by others
References
Abdallah B. M.; Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene. Ther. 15: 109–116; 2007.
Baddoo M.; Hill K.; Wilkinson R.; Gaupp D.; Hughes C.; Kopen G. C.; Phinney D. G. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cellul. Biochem. 89: 1235–1249; 2003.
Baksh D.; Song L.; Tuan R. S. Adult mesenchymal stem cells. Characterization, differentiation and application in cell therapy. Mol. Med. 8: 301–136; 2004.
Baldwin H. S.; Shen H. M.; Yan H. C.; DeLisser H. M.; Chung A.; Mickanin C.; Trask T.; Kirschbaum N. E.; Newman P. J.; Albelda S. M.; et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120: 2539–2553; 1994.
Barry F. P. Mesenchymal stem cell therapy in joint disease. Novartis Found. Symp. 249: 86–96; 2003.
Bianco P.; Riminucci M.; Gronthos S.; Robey P. G. Bone marrow stromal stem cells. Nature, biology, and potential applications. Stem. Cells 19: 180–192; 2001.
Chapel A.; Bertho J. M.; Bensidhoum M.; Fouillard L.; Young R. G.; Frick J.; Demarquay C.; Cuvelier F.; Mathieu E.; Trompier F.; Dudoignon N.; Germain C.; Mazurier C.; Aigueperse J.; Borneman J.; Gorin N. C.; Gourmelon P.; Thierry D. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J. Gene Med. 5: 1028–1038; 2003.
Devine S. M.; Bartholomew A. M.; Mahmud N.; Nelson M.; Patil S.; Hardy W.; Sturgeon C.; Hewett T.; Chung T.; Stock W.; Sher D.; Weissman S.; Ferrer K.; Mosca J.; Deans R.; Moseley A.; Hoffman R. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp. Hematol. 29: 244–255; 2001.
Eslaminejad M. B.; Mirzadeh H.; Mohamadi Y.; Aghbibi N. Bone differentiation of the marrow-derived mesenchymal stem cells using β-tricalcium phosphate/alginate/gelatin hybrid scaffolds. J. Tiss. Eng. Reg. Med. 6: 417; 424; 2007.
Eslaminejad M. B.; Nadri S.; Hosseini R. H. Expression of Thy 1.2 surface antigen increases significantly during the murine MSCs cultivation period. Dev. Growth Differ. 49: 351–364; 2007.
Eslaminejad M. B.; Nikmahzar A.; Taghiyar L.; Nadri S.; Massumi M. Murine mesenchymal stem cells isolated by low density primary culture system. Dev. Growth Differ. 48: 361–370; 2006.
Friedenstein A. J.; Chailakhyan R. K.; Latsinik N. V.; Panansyuk A. F.; Keiliss-Borok I. V. Stromal cells responsible for transferring the microenvironment of the hematopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331–340; 1974b.
Friedenstein A. J.; Deriglasova U. F.; Kulagina N. N.; Panasuk A. F.; Rudakowa S. F.; Luriá E. A.; Ruadkow I. A. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay methods. Exp. Hematol. 2: 83–92; 1974a.
Grinnemo K. H.; Månsson A.; Dellgren G.; Klingberg D.; Wardell E.; Drvota V.; Tammik C.; Holgersson J.; Ringdén O.; Sylvén C.; Le Blanc K. Xenoreactivity and engraftment of human mesenchymal stem cells transplantation into infarcted rat myocardium. J. Thorac. Cardiovasc. Surg. 127: 1293–1300; 2004.
Horwitz E. M.; Gordon P. L.; Koo W. K.; Marx J. C.; Neel M. D.; McNall R. Y.; Muul L.; Hofmann T. Isolated allogenic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. U.S.A. 99: 8932–8937; 2002.
Ikuta K.; Weissman I. L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. U.S.A. 89: 1502–1506; 1992.
Jessop H. L.; Noble B. S.; Cryer A. The differentiation of a potential mesenchymal stem cells population within ovine bone marrow. Biochem. Soc. Trans. 22: 248; 1994.
Kadiyala S.; Young R. G.; Thiede M. A.; Bruder S. P. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant. 6: 125–134; 1997.
Kinashi T.; St Pierre Y.; Springer T. A. Expression of glycophosphatidylinositol-anchored and -non-anchored isoforms of vascular cell adhesion molecule 1 in murine stromal and endothelial cells. J. Leukoc. Biol. 57: 168–173; 1995.
Koe O. N.; Gerson S. L.; Cooper B. W.; Dyhonse S. M.; Haynesworth S. E.; Caplan A. I.; Lazarus H. M. Rapid hematopoietic recovery after confusion of autologous-blood stem cells in advanced breast cancer patients receiving high dose chemotherapy. J. Clin. Oncol. 18: 307–316; 2000.
Majumdar M. K.; Thiede M. A.; Mosa J. D.; Moorman M.; Gerson S. L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell Physiol. 176: 57–66; 1998.
Martin D. R.; Cox N. R.; Hathcock T. L.; Niemeyer G. P.; Baker H. J. Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp. Hematol. 308: 879–886; 2002.
Meirelles L. D. S.; Nardi N. B. Murine marrow derived mesenchymal stem cell. Isolation, in vitro expansion, and characterization. Brit. J. Hemat. 123: 702–711; 2003.
Mosca J. D.; Hendricks J. K.; Buyaner D.; Davis-Sproul J.; Chuang L. C.; Majumdar M. K.; Chopra R.; Barry F.; Murphy M.; Thiede M. A.; Junker U.; Rigg R. J.; Forestell S. P.; Böhnlein E.; Storb R.; Sandmaier B. M. Mesenchymal stem cells as vehicles for gene delivery. Clin. Orthop. 379: 71–90; 2000.
Nadri S.; Soleimani M. Isolation murine mesenchymal stem cells by positive selection. In Vitro Cell Dev. Biol. Anim. 43: 276–282; 2007.
Nadri S.; Soleimani M.; Hosseini R. H.; Massumi M.; Atashi A. An efficient method for isolation of murine bone marrow mesenchymal stem cells. Int. J. Dev. Biol. 51: 723–729; 2007.
Ogawa M.; Sugawara S.; Kunisada T.; Sudo T.; Hayashi S.; Nishikawa S.; Kodama H.; Nishikawa S. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse. Exp. Hematol. 26: 478–488; 1998.
Osawa M.; Hanada K.; Hamada H.; Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273: 242–245; 1996.
Peister A.; Mellad J. A.; Larsen L. L.; Hall B. M.; Gibson L. F.; Prockop D. J. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103: 1662–1668; 2004.
Petite H.; Viateau V.; Bensaid W.; Meunier A.; Depollak C.; Bourguignon M.; Oudina K.; Sedel L.; Guillemin G. Tissue engineered bone regeneration. Nat. Biotechnol. 18: 959–963; 2000.
Pittenger M. F.; Mackay A. M.; Beck S. C.; Jaiswal R. K.; Douglas R.; Mosca J. D.; Moorman M. A.; Simonetti D. W.; Craig S.; Marshak D. R. Multilineage potential of adult human mesenchymal stem cells. Science 248: 143–147; 1999.
Quarto R.; Mastrogiacomo M.; Cancedda R.; Kutepdda S. M.; Mukhachev V.; Lavroukov A.; Kon E.; Marcacci M. Repair of large bone defect with the use of autogenic bone marrow stromal cell. N. Engl. J. Med. 344: 385–386; 2001.
Ringe J.; Kaps C.; Schmitt B.; Buscher K.; Bartel J.; Smolian H.; Schultz O.; Burmester G. R.; Haupl T.; Sittinger M. Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell Tissue Res. 307: 321–327; 2002.
Shao X.; Goh J. C.; Hutmacher D. W.; Lee E. H.; Zigang G. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in rabbit model. Tissue Eng. 12: 1539–1551; 2006.
Sugaya K. Potential use of stem cells in neuro-replacement therapies for neurodegenerative diseases. Int. Rev. Cytol. 228: 1–30; 2003.
Sun S.; Guo Z.; Xiao X.; Liu B.; Liu X.; Tang P. H.; Mao N. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem. Cells 21: 527–535; 2003.
Tropel P.; Noel D.; Platet N.; Legrand P.; Benabid A. L.; Berger F. Isolation and characterization of mesenchymal stem cells from adult mouse bone marrow. Exp. Cell Res. 295: 395–406; 2004.
Xian C. J.; Foster B. K. Repair of injured articular and growth plate cartilage using mesenchymal stem cells and chondrogenic gene therapy. Curr. Stem. Cell Res. Ther. 1: 213–229; 2006.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: J. Denry Sato
Rights and permissions
About this article
Cite this article
Eslaminejad, M.B., Nadri, S. Murine mesenchymal stem cell isolated and expanded in low and high density culture system: surface antigen expression and osteogenic culture mineralization. In Vitro Cell.Dev.Biol.-Animal 45, 451–459 (2009). https://doi.org/10.1007/s11626-009-9198-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-009-9198-1